3rd Annual Pharmaceutical Pricing & Reimbursement in Central & Eastern Europe

Event Overview

This event will present the most updated and original perspectives on communicating the cost-effectiveness of high valued drugs to key stakeholders in the former communist countries of Central and Eastern Europe (CEE EU members, The Balkans, Russia and the former Soviet states).

In the current economic environment, when healthcare budgets are more restricted then ever, cost-effectiveness and budget-impact considerations are playing a vital role in payers' reimbursement decisions.

Market-access in CEE under these conditions is becoming more challenging and requires professionals to constantly innovate in product-value demonstration and more recently, consider and implement innovative reimbursement schemes.

The conference will be unique because unlike other general, pan-European pricing & reimbursement meetings or broadly-focused CEE Pharma events, it will specifically focus on pricing & reimbursement of high value drugs in the CEE region. All participants will be gain first-hand exposure to the decision-making processes in the region’s key markets and will gain a clear understanding of the different reforms and changing requirements which will soon come into effect.

Why attend in 2010?

• Learn which innovative reimbursement schemes can be implemented in CEE
• Understand the drivers for risk-sharing and value-based pricing schemes in the region
• Learn how HTAs are evolving in CEE, their priorities and methodologies and understand the best approaches to achieving maximum market access in the region.
• Find out how health budgets are being affected in the global financial crisis
• Understand how payers are evaluating various reimbursement models
• Get the recent updates on market-access in Russia & CIS: What new opportunities are out there and how can they be realised?
• Hear which reforms are taking place now in key CEE countries
• Obtain new information on the latest on health-systems re-structure and trends
• Benchmark, network and co-operate with policy makers , key opinion leaders , payers, pharma companies, academia and patient groups.

Who will benefit:

Pharmaceutical manufacturers: Vice-Presidents, Directors, Managers involved in:
Pricing & Reimbursement, Health Outcomes, Government Affairs, Regulatory Affairs, Medical, Marketing, CEE Heads, Country Heads, Pre-Marketing / Clinical Data Collection.

Solution providers & consultants: CEOs, Business Development, Senior Consultants, Regional Heads.

Independent Academics, Health Economists, Senior Doctors & Patient Representatives.

A more detailed list of speakers’ names is available on the downloadable agenda. Please „request event agenda“ below. 

Your Prestigious Speaker Panel: